Cargando…
In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea.
Gemifloxacin is an enhanced-affinity fluoroquinolone with broad-spectrum antibacterial activity. In Korea, resistant bacteria are relatively more prevalent than in other industrialized countries. In this study, we studied the in vitro activities of gemifloxacin, gatifloxacin, moxifloxacin, levofloxa...
Autores principales: | Yong, Dong Eun, Cheong, Hee-Jin, Kim, Yang Soo, Park, Yeon Joon, Kim, Woo-Joo, Woo, Jun Hee, Lee, Kyung Won, Kang, Moon Won, Choo, Youn-Sung |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054972/ https://www.ncbi.nlm.nih.gov/pubmed/12482994 |
Ejemplares similares
-
Clinical Effects of Gemifloxacin on the Delay of Tuberculosis Treatment
por: Kim, Seo Yun, et al.
Publicado: (2013) -
Biphasic anaphylaxis to gemifloxacin
por: Yilmaz, İnsu, et al.
Publicado: (2012) -
Immunomodulatory activities of gemifloxacin in mice
por: Umair, Muhammad, et al.
Publicado: (2016) -
Molecular Epidemiology of Human Adenovirus–Associated Febrile Respiratory Illness in Soldiers, South Korea(1)
por: Heo, Jung Yeon, et al.
Publicado: (2018) -
Ion-pair spectrophotometric estimation of gemifloxacin
por: Sahu, Satyabrata, et al.
Publicado: (2012)